DANIEL CHILDS, M.D.
Medical Oncology Physician · ROCHESTER, MN
Individual Active NPI 1851770036
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 509 | 86,545 | $7,690,402 | $2,522,070 | $2,005,526 |
| 2023 | 452 | 75,477 | $6,195,354 | $2,028,419 | $1,613,584 |
| 2022 | 86 | 144 | $52,819 | $21,322 | $16,077 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 9,806 | $54 | $43 |
| J9267 | Injection, paclitaxel, 1 mg | 8,466 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 7,650 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 5,120 | $29 | $23 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,041 | $49 | $39 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 3,800 | $0 | $0 |
| J9034 | Injection, bendamustine hcl (bendeka), 1 mg | 2,235 | $14 | $11 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,242 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 1,085 | $2 | $1 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 980 | $1 | $1 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 788 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 418 | $16 | $13 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | 61017 | MN |
| Internal Medicine Physician | 207R00000X | 61017 | MN | |
| Hematology & Oncology Physician | 207RH0003X | 61017 | MN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Minnesota
- NPI 1437278959
- NPI 1003376468
- NPI 1982680583
- NPI 1801877501
- NPI 1437136553
- NPI 1417148180
- NPI 1306879028
- NPI 1265729834
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.